American Peptide Company, Inc. announced its new Total Peptide Management program to help the pharmaceutical and life sciences industries bring new and innovative drugs to market faster. Total Peptide Management offers a broad portfolio of peptides, value-added services, and expert consultation to support customer needs as their drug products move from discovery to development and commercialization.

The program is a customized service platform, which comprises a set of comprehensive services, including process development; scale-up production; analytical and process validation; stability studies; Chemistry, Manufacturing, and Controls (CMC); Drug Master Files (DMF) and regulatory support.  This platform complements the company’s suite of advanced peptides to provide customers with efficient, high-quality and cost-effective peptide management solutions.

Additionally, the program facilitates greater adherence to manufacturing standards and protocols at the company’s manufacturing facilities.  It mandates application of GMP practices to non-GMP applications in the early phases of drug development to provide drug researchers with manufacturing processes that can be scaled up efficiently.

As part of the program, the company provides peptides in a timely and cost-effective manner to drug manufacturers. The high-quality of these peptides helps manufacturers realize improved consistency, with higher yields and reliable product quality.  This helps companies looking to commercialize their product significantly reduce their total operations cost, as well as speed time to market.

www.americanpeptide.com